|
|
|
| Influencing factors for treatment outcomes among pulmonary tuberculosis patients with positive etiological results in Anji County from 2015 to 2024 |
| YOU Jicun, TIAN Lei, WANG Xinjia, ZHANG Xiqin
|
| Anji County Center for Disease Control and Prevention (Anji County Institute of Public Health Supervision), Anji, Zhejiang 313300, China |
|
|
|
|
Abstract Objective To analyze the treatment outcomes and influencing factors among pulmonary tuberculosis patients with positive etiological results in Anji County, Zhejiang Province from 2015 to 2024, so as to provide evidence for improving the successful treatment rate of pulmonary tuberculosis and interrupting its transmission. Methods Data on pulmonary tuberculosis patients with positive etiological results registered and managed in Anji County from January 1, 2015 to December 31, 2024 were collected through the Tuberculosis Information Management System of the Chinese Disease Prevention and Control Information System. The data included demographic information, healthcare-seeking delay, treatment category, and etiological results. The successful treatment rate was analyzed. Factors affecting treatment outcomes among pulmonary tuberculosis patients with positive etiological results were identified using a multivariable logistic regression model. Results A total of 1 249 pulmonary tuberculosis patients with positive etiological results registered and managed in Anji County from 2015 to 2024 were included. There were 858 males (68.69%) and 391 females (31.31%). The median age was 60.00 (interquartile range, 31.00) years. From 2015 to 2024, 1 128 patients achieved successful treatment, with a successful treatment rate of 90.31%. The trend was not statistically significant (P>0.05). There were 121 patients with adverse treatment outcomes, primarily consisting of treatment discontinuation due to adverse reactions and deaths, with 49 and 26 patients, respectively. Multivariable logistic regression analysis showed that female (OR=2.118, 95%CI: 1.300-3.451), age <80 years (<40 years, OR=4.166, 95%CI: 2.108-8.232; 40-<60 years, OR=3.211, 95%CI: 1.751-5.890; 60-<80 years, OR=3.137, 95%CI: 1.835-5.365), absence of healthcare-seeking delay (OR=1.535, 95%CI: 1.037-2.271), and initial treatment (OR=1.965, 95%CI: 1.131-3.414) were associated with a higher likelihood of successful treatment among pulmonary tuberculosis patients with positive etiological results. Conclusions The successful treatment rate among pulmonary tuberculosis patients with positive etiological results in Anji County from 2015 to 2024 was generally high and remained stable. Gender, age, healthcare-seeking delay, and treatment category were associated with treatment success.
|
|
Received: 27 January 2026
Revised: 01 April 2026
Published: 21 April 2026
|
|
|
|
|
|
[1] 王微. 基于结核病的流行趋势与防控[J].世界最新医学信息文摘,2019,19(70):215-238.
[2] 屈燕,李涛,马文斌,等.世界卫生组织《2025年全球结核病报告》解读[J].结核与肺部疾病杂志,2025,6(6):613-623.
[3] 浙江省爱国卫生运动委员会(浙江省健康浙江建设领导小组)办公室.2025年健康浙江建设工作要点和考核实施方案[Z].2025.
[4] 中华人民共和国国家卫生和计划生育委员会.肺结核诊断:WS 288—2017[S].北京:中国标准出版社,2017.
[5] 周林,刘二勇,孟庆琳,等.《WS 288—2017肺结核诊断》标准实施后肺结核诊断质量评估分析[J].中国防痨杂志,2020,42(9):910-915.
[6] 李江红,刘芳,杨枢敏,等.甘肃省县(区)级结核病定点医院病原学阴性肺结核诊断质量调查分析[J].中国防痨杂志,2024,46(12):1478-1484.
[7] 陈可,李锦成,虞浩,等.扬州市65岁及以上老年人群肺结核流行特征分析[J].预防医学,2023,35(10):877-880.
[8] 中国疾病预防控制中心结核病控制中心.中国结核病防治规划实施工作指南(2008年版)[EB/OL][2026-04-01].https://tb.chinacdc.cn/zcfg/sszn/201207/t20120711_64166.htm.
[9] 中国疾病预防控制中心.中国结核病防治工作技术指南[EB/OL][2026-04-01].https://www.chinacdc.cn/jkyj/crb2/yl/fjh/jswj_fjh/202410/P020241010432930570191.pdf.
[10] 徐睿,安兴洪,范厚红,等.2019—2023年都匀市病原学阳性肺结核流行病学特征及治疗转归分析[J].职业卫生与病伤,2025,40(5):274-280.
[11] 谭家婷,范厚红.2018—2022年平塘县病原学阳性肺结核流行特征分析[J].寄生虫病与感染性疾病,2025,23(1):25-30.
[12] 杨超,王晶,谢珂,等.2012—2021年北京市通州区病原学阳性肺结核流行特征及治疗转归分析[J].结核与肺部疾病杂志,2023,4(2):128-134.
[13] 谢祎,韩晶,于维莉,等.天津市肺结核患者短程督导治疗期抗结核治疗效果及死亡影响因素分析[J].中国公共卫生,2020,36(1):126-129.
[14] LI S J,LI Y F,SONG W M,et al.Population aging and trends of pulmonary tuberculosis incidence in the elderly[J/OL].BMC Infect Dis,2021,21(1)[2026-04-01].https://doi.org/10.1186/s12879-021-05994-z.
[15] 陈淑贤,徐雅斐,侯义.2015—2024年河南省洛阳市利福平耐药肺结核患者流行病学特征[J].现代疾病预防控制,2025,36(8):581-586.
[16] 陶桃,张海芳,凡鹏飞,等.丽水市老年肺结核患者治疗转归的影响因素分析[J].预防医学,2025,37(9):892-902.
[17] 中华医学会结核病学分会.老年肺结核诊断与治疗专家共识(2023版)[J].中华结核和呼吸杂志,2023,46(11):1068-1084.
[18] 熊丽芬,李思,杨茜茹,等.2016—2024年云南省西双版纳州病原学阳性肺结核患者特征及治疗2个月末痰菌未阴转的影响因素分析[J].中国防痨杂志,2025,47(增刊2):27-31.
[19] 马煜,杜昕,邓亚丽,等.陕西省2015—2019年学生肺结核患者就诊延迟影响因素分析[J].中国学校卫生,2021,42(4):615-618,622.
[20] 廖小刚,谭佳容,伍侨,等.中国老年肺结核患者就诊延迟率的Meta分析[J].中国循证医学杂志,2022,22(5):558-567.
[21] 王荣,李晨,杨晨,等.南京市2011—2013年肺结核患者就诊延迟状况及影响因素分析[J].中华疾病控制杂志,2015,19(8):854-856.
[22] 马晓雪,王大福,陈再平,等.2017—2022年贵州省肺结核患者治疗转归及影响因素分析[J].现代预防医学,2024,51(6):1129-1134.
[23] 陈丽,秦雪玲,张念伦,等.2020—2023年65岁及以上老年人肺结核患者耐药情况及影响因素分析[J].中国防痨杂志,2025,47(增刊2):23-26. |
|
|
|
